Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida
- PMID: 7490047
- PMCID: PMC1195546
- DOI: 10.1136/sti.71.5.304
Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida
Abstract
Introduction: Although as many as 5% of all women complain of chronic vulvovaginitis, little is known about these women. They may often be misdiagnosed and the role of vaginal yeast culture in diagnosing vulvovaginal candidiasis (VVC) among them has not been clearly defined.
Methods: To address these deficiencies, we tabulated initial diagnoses among new patients and conducted a medical record-based, unmatched case-control study among women reporting a history of chronic vulvovaginitis (four or more episodes in the past year) at a vulvovaginitis specialty clinic. Clinical presentation and medical history were compared for women who had a positive vaginal yeast culture for either Candida albicans or C glabrata, or who had a negative culture.
Results: One-third of the women had no apparent vulvovaginal disease at their initial visit. All women reported similar symptoms, except for an increased prevalence of painful sexual intercourse in women with C albicans (chi 2 p = 0.014 versus women with C glabrata and p < 0.001 versus women with no candida). Women with C glabrata were more likely to be non-white (chi 2 p = 0.071 compared with women with C albicans) and to report an underlying medical condition (chi 2 p < or = 0.001 versus both women with C albicans and women with no candida). Physical examination was normal only in women with no candida. C albicans cases were more likely to have positive potassium hydroxide microscopy (chi 2 p = 0.016) and a pH < or = 4.5 (chi 2 p = 0.011) than were C glabrata cases.
Conclusions: These results suggest that reliance on symptoms and signs alone will result in significant misdiagnosis of chronic vulvovaginitis. Among women with VVC, subtle differences in clinical presentation do not reliably distinguish women with C albicans from those with C glabrata. Our study also indicates that vaginal yeast cultures, while not necessary for every patient, are valuable in confirming negative diagnoses, detecting microscopy false-negatives, and identifying non-C albicans isolates.
Similar articles
-
Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).Mycoses. 2015 Mar;58 Suppl 1:1-15. doi: 10.1111/myc.12292. Mycoses. 2015. PMID: 25711406
-
Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.J Infect. 2006 Feb;52(2):111-7. doi: 10.1016/j.jinf.2005.03.005. J Infect. 2006. PMID: 15908007
-
Comparison of enzymatic activities in different Candida species isolated from women with vulvovaginitis.J Mycol Med. 2017 Jun;27(2):188-194. doi: 10.1016/j.mycmed.2017.01.009. Epub 2017 Feb 21. J Mycol Med. 2017. PMID: 28236530
-
[Vulvovaginal candidiasis: a therapeutic approach].Minerva Ginecol. 2005 Apr;57(2):131-9. Minerva Ginecol. 2005. PMID: 15940073 Review. Italian.
-
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27. Mycoses. 2021. PMID: 33529414 Free PMC article. Review.
Cited by
-
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.Clin Microbiol Rev. 1999 Jan;12(1):80-96. doi: 10.1128/CMR.12.1.80. Clin Microbiol Rev. 1999. PMID: 9880475 Free PMC article. Review.
-
The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis.Pharm World Sci. 2003 Aug;25(4):177-81. doi: 10.1023/a:1024842712675. Pharm World Sci. 2003. PMID: 12964498
-
Candidiasis (vulvovaginal).BMJ Clin Evid. 2015 Mar 16;2015:0815. BMJ Clin Evid. 2015. PMID: 25775428 Free PMC article.
-
Vulvovaginal candidiasis.Sex Transm Infect. 2006 Dec;82 Suppl 4(Suppl 4):iv28-30. doi: 10.1136/sti.2006.023168. Sex Transm Infect. 2006. PMID: 17151050 Free PMC article. No abstract available.
-
Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections.Sex Transm Infect. 2001 Jun;77(3):212-3. doi: 10.1136/sti.77.3.212. Sex Transm Infect. 2001. PMID: 11402233 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous